Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Rituximab can cause skin issues, but baricitinib may help improve them.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Individualized treatments may help manage Dercum's disease symptoms.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Denosumab may cause alopecia areata.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Infliximab may cause hair loss in Crohn's disease patients.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Baricitinib improved hair loss and arthritis in a lupus patient.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Brodalumab effectively treated a man's severe hand and foot psoriasis.